Aktis Oncology, Inc. (AKTS)
18.14
+0.40
(+2.23%)
USD |
NASDAQ |
Oct 09, 16:00
18.14
0.00 (0.00%)
After-Hours: 17:41
Aktis Oncology Price : 18.14 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 17.86 | 17.96 | 16.99 | 17.74 | 500842.0 |
| Oct 07, 2026 | 17.72 | 18.35 | 17.70 | 18.00 | 294105.0 |
| Oct 06, 2026 | 18.64 | 18.75 | 17.81 | 17.86 | 294763.0 |
| Oct 05, 2026 | 18.47 | 18.68 | 17.84 | 18.52 | 282981.0 |
| Oct 02, 2026 | 18.75 | 18.82 | 17.93 | 18.52 | 337989.0 |
| Oct 01, 2026 | 19.41 | 20.08 | 18.31 | 18.52 | 305211.0 |
| Sep 30, 2026 | 19.83 | 19.87 | 19.23 | 19.47 | 277271.0 |
| Sep 29, 2026 | 19.30 | 19.72 | 19.06 | 19.69 | 194719.0 |
| Sep 28, 2026 | 19.24 | 19.46 | 19.05 | 19.35 | 223200.0 |
| Sep 25, 2026 | 19.71 | 19.81 | 18.96 | 19.43 | 518913.0 |
| Sep 24, 2026 | 19.74 | 20.45 | 19.43 | 19.63 | 384968.0 |
| Sep 23, 2026 | 21.87 | 21.87 | 19.67 | 19.72 | 589437.0 |
| Sep 22, 2026 | 21.69 | 22.22 | 21.45 | 22.11 | 302013.0 |
| Sep 21, 2026 | 22.06 | 22.06 | 20.75 | 21.43 | 614263.0 |
| Sep 18, 2026 | 22.86 | 23.08 | 21.88 | 21.88 | 2.729M |
| Sep 17, 2026 | 23.04 | 23.97 | 22.44 | 22.86 | 500880.0 |
| Sep 16, 2026 | 22.48 | 22.94 | 21.31 | 22.71 | 855045.0 |
| Sep 15, 2026 | 23.21 | 23.21 | 22.18 | 22.41 | 290432.0 |
| Sep 14, 2026 | 23.36 | 23.70 | 22.79 | 23.17 | 330076.0 |
| Sep 11, 2026 | 24.36 | 24.54 | 23.25 | 23.30 | 228578.0 |
| Sep 10, 2026 | 23.80 | 24.36 | 23.57 | 23.94 | 263618.0 |
| Sep 09, 2026 | 25.57 | 26.00 | 24.03 | 24.06 | 377363.0 |
| Sep 08, 2026 | 26.99 | 26.99 | 24.23 | 25.02 | 567427.0 |
| Sep 04, 2026 | 26.18 | 27.20 | 26.18 | 27.05 | 159249.0 |
| Sep 03, 2026 | 27.29 | 27.66 | 26.08 | 26.65 | 152776.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.52 |
| Savara, Inc. | 4.925 |
| Vericel Corp. | 40.09 |
| Biogen, Inc. | 225.81 |
Price Related Metrics
| PS Ratio | 98.62 |
| PEG Ratio | -0.0774 |
| Price to Book Value | 2.069 |
| Earnings Yield | -7.60% |
| Market Cap | 1.003B |
| PEGY Ratio | -0.0774 |